# Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

> **NCT02872103** · PHASE3 · COMPLETED · sponsor: **EVIVE Biotechnology** · enrollment: 122 (actual)

## Conditions studied

- Breast Cancer
- Neutropenia

## Interventions

- **DRUG:** F-627
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02872103
- **Lead sponsor:** EVIVE Biotechnology
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08
- **Primary completion:** 2017-12-20
- **Final completion:** 2017-12-20
- **Target enrollment:** 122 (ACTUAL)
- **Last updated:** 2021-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02872103

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02872103, "Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02872103. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*